[1] |
Huang SQ, Tang CL, Sun SQ, et al. Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rat[J]. CNS Neurosci Ther, 2014, 20(1): 20-31. DOI: 10.1111/cns.12155.
|
[2] |
Furlan JC, Noonan V, Cadotte DW, et al. Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies[J]. J Neurotrauma, 2011, 28(8): 1371-1399. DOI: 10.1089/neu.2009.1147.
|
[3] |
梁益建,孙善全,汪克建,等. 大鼠脊髓慢性压迫性损伤实验模型的建立[J].中国临床解剖学杂志, 2006, 24(3):320-324. DOI:10.13418/j.issn.1001-165x.2006.03.034.
|
[4] |
Wnęk A, Andrzejewska E, Kobos J, et al. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment[J]. Immunol Lett, 2017, 185: 27-31.DOI: 10.1016/j.imlet. 2017.03.005.
|
[5] |
Erschbamer M, Pernold K, Olson L. Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury[J]. J Neurosci, 2007, 27: 6428-6435. DOI: 10.1523/JNEUROSCI.1037-07.2007.
|
[6] |
Li ZW, Li JJ, Wang L, et al. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury[J]. J Neuroinflammation, 2014, 11: 71. DOI: 10.1186/1742-2094-11-71.
|
[7] |
Sharp K, Yee KM, Steward O. A re-assessment of the effects of treatment with an epidermal growth factor receptor (EGFR) inhibitor on recovery of bladder and locomotor function following thoracic spinal cord injury in rats[J]. Exp Neurol, 2012, 233(2): 649-659. DOI: 10.1016/j.expneurol.2011.04.013.
|
[8] |
Wen QQ, Zhang X, Cai JY, et al. A novel strategy for real-time and in situ detection of cytochrome c and caspase-9 in Hela cells during apoptosis[J]. Analyst, 2014, 139(10): 2499-2506. DOI: 10.1039/c3an02205f.
|
[9] |
Wu Y, Kimura Y, Okamoto T, et al, et al. Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL-induced caspase activation[J]. Sci Rep, 2019, 9(1): 20301. DOI: 10.1038/s41598-019-56748-6.
|
[10] |
de Miguel D, Lemke J, Anel A, et al. Onto better TRAILs for cancer treatment[J]. Cell Death Differ, 2016, 23(12): 733-747. DOI: 10.1038/cdd.2015.174.
|